Swiss

Index
Globenewswire

Ascom Myco 4 Becomes the World’s First 5G Phone Certified for Mission-Critical Services

Globenewswire

Swiss President’s Message to UEFA Women’s EURO 2025 Fans in Heartwarming New Video: Even if You Lose, You Win in Switzerland

Globenewswire

Sportradar Expands Industry-Leading Soccer Portfolio with FIFA Club World Cup 2025 Rights

Globenewswire

Sandoz Launches First and Only Interchangeable Denosumab Biosimilars in US, Providing New Affordable Treatment Options for Over 10 Million Patients[1]

Globenewswire

Ascom Launches Share Buyback Program

Globenewswire

Sandoz Launches Pyzchiva® Autoinjector, First Commercially Available in Europe for Ustekinumab Biosimilars

Globenewswire

ABB Introduces Battery Energy Storage Systems-as-a-Service to Simplify Renewable Energy Adoption

Globenewswire

Medela Introduces Magic InBra™ With FluidFeel Technology™—Where Science Meets Uncompromising Care

Globenewswire

Acronis Ecosystem Reaches 300 Technology Integrations, Drives New Opportunities for MSPs and ISVs

Globenewswire

Sandoz Reports Q1 2025 Net Sales in Line with Company Expectations; Full-year Guidance Confirmed

Globenewswire

Sandoz Enters Global Collaboration License Agreement with Henlius to Commercialize Leading Oncology Therapy, Ipilimumab, in Multiple Indications

Globenewswire

Sportradar Announces Pricing of Public Offering of Class A Ordinary Shares by Selling Shareholders and Concurrent Share Repurchase

Globenewswire

Sportradar Announces Preliminary First Quarter 2025 Financial Results

Globenewswire

Sportradar Announces Launch of Public Offering of Class A Ordinary Shares by Selling Shareholders and Concurrent Share Repurchase

Globenewswire

CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA

Globenewswire

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

Globenewswire

Ascom Annual General Meeting Approves All Proposals of the Board of Directors

Globenewswire

[Corrected] Sandoz Files Antitrust Litigation Against Amgen Regarding Patient Access to Etanercept Biosimilar in the US

Globenewswire

Sandoz Files Antitrust Litigation Against Amgen Regarding Patient Access to Etanercept Biosimilar in the US

Globenewswire

Boehringer Ingelheim Strengthens Antibody-drug Conjugate Portfolio with New NBE Therapeutics R&D Center in Basel

Globenewswire

Sandoz Strengthens its Balance Sheet By Issuing New Bonds to Repay Spin-off Term Loans, and Signs New USD 2 Billion Revolving Credit Facility

Globenewswire

EAACI Congress 2025 - Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future

Globenewswire

Kongres EAACI 2025 - Mendobrak Batasan dalam Alergi, Asma, dan Imunologi Klinis: Mengintegrasikan Kesehatan Planet untuk Masa Depan Berkelanjutan

Globenewswire

Ascom Affected by Cyber Attack

Globenewswire

Acronis 2024 ESG Report Highlights a Year of Commitment to Sustainability Growth, Cybersecurity Leadership, and Social Impact